Cargando…
Immune Metabolism in TH2 Responses: New Opportunities to Improve Allergy Treatment — Disease-Specific Findings (Part 1)
PURPOSE OF REVIEW: Recent high-level publications have shown an intricate connection between immune effector function and the metabolic state of the respective cells. In the last years, studies have begun analyzing the metabolic changes associated with allergies. As the first part of a two-article s...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832111/ https://www.ncbi.nlm.nih.gov/pubmed/36441389 http://dx.doi.org/10.1007/s11882-022-01057-8 |
_version_ | 1784867993064308736 |
---|---|
author | Goretzki, A. Zimmermann, J. Rainer, H. Lin, Y.-J. Schülke, Stefan |
author_facet | Goretzki, A. Zimmermann, J. Rainer, H. Lin, Y.-J. Schülke, Stefan |
author_sort | Goretzki, A. |
collection | PubMed |
description | PURPOSE OF REVIEW: Recent high-level publications have shown an intricate connection between immune effector function and the metabolic state of the respective cells. In the last years, studies have begun analyzing the metabolic changes associated with allergies. As the first part of a two-article series, this review will briefly summarize the basics of immune metabolism and then focus on the recently published studies on metabolic changes observed in allergic patients. RECENT FINDINGS: In the last 3 years, immune-metabolic research in allergology had a clear focus on asthma with some studies also reporting findings in food allergy and atopic dermatitis. Current results suggest asthma to be associated with a shift in cellular metabolism towards increased aerobic glycolysis (Warburg metabolism), while also displaying substantial changes in fatty acid- and amino acid metabolism (depending on investigated patient collective, asthma phenotype, and disease severity). SUMMARY: Understanding immune-metabolic changes in allergies will allow us to (I) better understand allergic disease pathology and (II) modulate immune-metabolic pathways to improve allergy treatment. |
format | Online Article Text |
id | pubmed-9832111 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-98321112023-01-12 Immune Metabolism in TH2 Responses: New Opportunities to Improve Allergy Treatment — Disease-Specific Findings (Part 1) Goretzki, A. Zimmermann, J. Rainer, H. Lin, Y.-J. Schülke, Stefan Curr Allergy Asthma Rep Allergens (RK Bush and S Vieths, Section Editors) PURPOSE OF REVIEW: Recent high-level publications have shown an intricate connection between immune effector function and the metabolic state of the respective cells. In the last years, studies have begun analyzing the metabolic changes associated with allergies. As the first part of a two-article series, this review will briefly summarize the basics of immune metabolism and then focus on the recently published studies on metabolic changes observed in allergic patients. RECENT FINDINGS: In the last 3 years, immune-metabolic research in allergology had a clear focus on asthma with some studies also reporting findings in food allergy and atopic dermatitis. Current results suggest asthma to be associated with a shift in cellular metabolism towards increased aerobic glycolysis (Warburg metabolism), while also displaying substantial changes in fatty acid- and amino acid metabolism (depending on investigated patient collective, asthma phenotype, and disease severity). SUMMARY: Understanding immune-metabolic changes in allergies will allow us to (I) better understand allergic disease pathology and (II) modulate immune-metabolic pathways to improve allergy treatment. Springer US 2022-11-28 2023 /pmc/articles/PMC9832111/ /pubmed/36441389 http://dx.doi.org/10.1007/s11882-022-01057-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Allergens (RK Bush and S Vieths, Section Editors) Goretzki, A. Zimmermann, J. Rainer, H. Lin, Y.-J. Schülke, Stefan Immune Metabolism in TH2 Responses: New Opportunities to Improve Allergy Treatment — Disease-Specific Findings (Part 1) |
title | Immune Metabolism in TH2 Responses: New Opportunities to Improve Allergy Treatment — Disease-Specific Findings (Part 1) |
title_full | Immune Metabolism in TH2 Responses: New Opportunities to Improve Allergy Treatment — Disease-Specific Findings (Part 1) |
title_fullStr | Immune Metabolism in TH2 Responses: New Opportunities to Improve Allergy Treatment — Disease-Specific Findings (Part 1) |
title_full_unstemmed | Immune Metabolism in TH2 Responses: New Opportunities to Improve Allergy Treatment — Disease-Specific Findings (Part 1) |
title_short | Immune Metabolism in TH2 Responses: New Opportunities to Improve Allergy Treatment — Disease-Specific Findings (Part 1) |
title_sort | immune metabolism in th2 responses: new opportunities to improve allergy treatment — disease-specific findings (part 1) |
topic | Allergens (RK Bush and S Vieths, Section Editors) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832111/ https://www.ncbi.nlm.nih.gov/pubmed/36441389 http://dx.doi.org/10.1007/s11882-022-01057-8 |
work_keys_str_mv | AT goretzkia immunemetabolisminth2responsesnewopportunitiestoimproveallergytreatmentdiseasespecificfindingspart1 AT zimmermannj immunemetabolisminth2responsesnewopportunitiestoimproveallergytreatmentdiseasespecificfindingspart1 AT rainerh immunemetabolisminth2responsesnewopportunitiestoimproveallergytreatmentdiseasespecificfindingspart1 AT linyj immunemetabolisminth2responsesnewopportunitiestoimproveallergytreatmentdiseasespecificfindingspart1 AT schulkestefan immunemetabolisminth2responsesnewopportunitiestoimproveallergytreatmentdiseasespecificfindingspart1 |